54230-90-9 Usage
Uses
Used in Pharmaceutical Industry:
8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine is used as an intermediate compound for the synthesis of more complex pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Academic Research:
8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine is used as a research compound in academic settings, where scientists explore its chemical properties and potential interactions with biological systems. This can lead to a better understanding of its role in drug development and pharmacological studies.
Safety and Handling:
The safety, handling, and potential health effects of 8-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine are detailed in its Material Safety Data Sheet (MSDS). It is essential to follow the guidelines provided in the MSDS to ensure safe handling and minimize any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 54230-90-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,2,3 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54230-90:
(7*5)+(6*4)+(5*2)+(4*3)+(3*0)+(2*9)+(1*0)=99
99 % 10 = 9
So 54230-90-9 is a valid CAS Registry Number.
54230-90-9Relevant academic research and scientific papers
BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS
-
Page/Page column 79; 83; 84, (2019/08/26)
The present invention relates to compounds of general formula (I), wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.
HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
-
, (2009/10/30)
The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
-
, (2009/10/17)
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
